J. Roh et al. / Tetrahedron Letters 51 (2010) 1411–1414
1413
Table 1
6. Roh, J.; Artamonova, T. V.; Vavrova, K.; Koldobskii, G. I.; Hrabalek, A. Synthesis
2009, 13, 2175.
Preparation of 5-substituted 2-vinyl-2H-tetrazoles
7. (a) Koldobskii, G. I. Russ. J. Org. Chem. 2006, 42, 469; (b) Couri, M. R.; Luduvico,
I.; Santos, L.; Alves, R.; Prado, M. A.; Gil, R. F. Carbohydr. Res. 2007, 342, 1096; (c)
Efimova, J. A.; Mashkova, E. A.; Artamonova, T. V.; Koldobskii, G. I. Chem.
Heterocycl. Compd. 2008, 44, 498.
8. (a) Katritzky, A. R.; Cai, C.; Meher, N. K. Synthesis 2007, 1204; (b) Artamonova, T.
V.; Zhivich, A. B.; Dubinskii, M. Y.; Koldobskii, G. I. Synthesis 1996, 1428.
9. Davydov, D. V.; Beletskaya, I. P.; Gorovoy, M. S. Tetrahedron Lett. 2002, 43, 6221.
10. Koldobskii, G. I.; Kharbash, R. B. Russ. J. Org. Chem. 2003, 39, 453.
11. Vereshchagin, L. I.; Buzilova, S. R.; Mityukova, T. K.; Proidakov, A. G.;
Kizhnyaev, V. N. Zh. Org. Khim. 1986, 22, 1979.
12. (a) Finnegan, W.; Henry, R. J. Org. Chem. 1959, 24, 1565; (b) Moody, C. J. Chem.
Soc., Perkin Trans. 1 1991, 323; (c) Moody, C. J. Chem. Soc., Perkin Trans. 1 1991,
329.
Product
R-
Time (h)
4
Yield (%)
80
2a
13. Taillefer, M.; Ouali, A.; Renard, B.; Spindler, J.-F. Chem. Eur. J. 2006, 12, 5301.
14. Fleming, A.; Kelleher, F.; Mahon, M. F.; McGinley, J.; Prajapati, V. Tetrahedron
2005, 61, 7002.
2b
2c
4
4
75
79
15. Vidal, F. J .Org. Chem. 1959, 24, 680.
16. Preparation of trimethyl-2-(5-phenyl-2H-tetrazol-2-yl)ethylammonium bromide
(4): Potassium 5-phenyl-1H-tetrazolate (3.4 mmol) and (2-bromoethyl)trime-
thylammonium bromide (3.4 mmol) were added to 5 ml of N,N-dimeth-
ylformamide. The reaction mixture was stirred at 110 °C for 4 h, then cooled to
room temperature and the resulting solid was filtered, washed with CHCl3
(10 ml) and dried. The solid was dispersed in boiling ethanol (96%, 15 ml), KBr
was removed by filtration, the ethanolic filtrate was cooled and the product
crystallized by the addition of Et2O. Yield: 60%, mp 228–229 °C; 1H NMR
(300 MHz, D2O) d: 8.02–8.08 (m, 2H), 7.54–7.62 (m, 3H), 5.37 (t, J = 6.2 Hz, 2H),
4.21 (t, J = 6.2 Hz, 2H), 3.26 (s, 9H) ppm; 13C NMR (75 MHz, D2O) d: 164.9, 130.9,
128.8, 126.3, 125.3, 62.7, 53.2, 46.7 ppm; Anal. Calcd for C12H18BrN5: C, 46.16; H,
5.81; N, 22.43. Found: C, 45.77; H, 5.84; N, 22.43.
2d
2e
4
5
86
84
17. General method for the preparation of 5-substituted 2-vinyl-2H-tetrazoles: 1,2-
Dibromoethane (6 mmol) in MeCN (1.5 ml) was stirred at reflux. Then, a
solution of 5-substituted tetrazole (3 mmol) and Et3N (12 mmol) in MeCN
(2.5 ml) was added dropwise over 2 h. The mixture was heated at reflux for an
additional 2–3 h (overall reaction time is given in Table 1). The reaction was
monitored by TLC (mobile phase: hexane/Et2O). MeCN was removed under
reduced pressure, and the residue was dissolved in CHCl3 (30 ml) and washed
with H2O (3 Â 25 ml). The organic solution was dried over Na2SO4 and the
solvent was evaporated. The product was obtained by column
chromatography.
18. Data for compounds 2a–2k: 5-Phenyl-2-vinyl-2H-tetrazole (2a). Mobile phase:
hexane/Et2O, 15:1. Yield: 80%; mp 41 °C; 1H NMR (300 MHz, CDCl3) d: 8.17–
8.23 (m, 2H), 7.47–7.62 (m, 4H), 6.27 (dd, J = 15.6 and 1.5 Hz, 1H), 5.40 (dd,
J = 8.8 and 1.5 Hz, 1H) ppm; 13C NMR (75 MHz, CDCl3) d: 164.9, 130.6, 129.8,
128.9, 127.0, 126.9, 108.4 ppm; Anal. Calcd for C9H8N4: C, 62.78; H, 4.68; N,
32.54. Found: C, 62.55; H, 4.78; N, 32.64.
2f
4
77
78
2g
4.5
2h
2i
4.5
4
88
53
2j
CH3(CH2)10
–
4
4
54
5-p-Tolyl-2-vinyl-2H-tetrazole (2b): Mobile phase: hexane/Et2O, 10:1. Yield:
75%; mp 40–41 °C; 1H NMR (300 MHz, CDCl3) d: 8.08 (d, J = 8 Hz, 2H), 7.54 (dd,
J = 15.6 and 8.8 Hz, 1H), 7.31 (d, J = 8 Hz, 2H), 6.25 (dd, J = 15.6 and 1.5 Hz, 1H),
5.37 (dd, J = 8.8 and 1.5 Hz, 1H), 2.42 (s, 3H) ppm; 13C NMR (75 MHz, CDCl3) d:
164.9, 140.9, 129.8, 129.6, 127.0, 124.1, 108.2, 21.5 ppm; Anal. Calcd for
C10H10N4: C, 64.50; H, 5.41; N, 30.09. Found: C, 64.09; H, 5.45; N, 30.45.
5-(4-Nitrophenyl)-2-vinyl-2H-tetrazole (2c): Mobile phase: hexane/Et2O, 4:1.
Yield: 79%; mp 128–129 °C; 1H NMR (300 MHz, CDCl3) d: 8.28–8.48 (m, 4H),
7.59 (dd, J = 15.6 and 8.8 Hz, 1H), 6.32 (dd, J = 15.6 and 1.7 Hz, 1H), 5.48 (dd,
J = 8.8 and 1.7 Hz, 1H) ppm; 13C NMR (75 MHz, CDCl3) d: 163.0, 149.0, 132.8,
129.6, 127.9, 124.2, 109.5 ppm; Anal. Calcd for C9H7N5O2: C, 49.77; H, 3.25; N,
32.25. Found: C, 49.82; H, 3.52; N, 32.09.
2k
53/21a
a
NMR/isolated yield.
via a simple procedure without a metal catalyst or organocatalyst.
The resulting 5-substituted 2-vinyl-2H-tetrazoles can undergo
transformation of the double bond and can be used to prepare
3-substituted pyrazoles.12c
5-[4-(Trifluoromethyl)phenyl]-2-vinyl-2H-tetrazole (2d): Mobile phase: hexane/
Et2O, 10:1 Yield: 86%; mp 44 °C; 1H NMR (300 MHz, CDCl3) d: 8.32 (d,
J = 8.1 Hz, 2H), 7.77 (d, J = 8.1 Hz, 2H), 7.58 (dd, J = 15.6 and 8.8 Hz, 1H), 6.31
(dd, J = 15.6 and 1.6 Hz, 1H), 5.45 (dd, J = 8.8 and 1.6 Hz, 1H) ppm; 13C NMR
(75 MHz, CDCl3) d: 163.7, 132.4 (q, J = 32.8 Hz), 130.3, 129.7, 127.3, 125.9 (q,
J = 3.7 Hz), 123.8 (q, J = 272.3 Hz), 109.1 ppm; Anal. Calcd for C10H7F3N4: C,
50.01; H, 2.94; N, 23.33. Found: C, 49.99; H, 2.82; N, 23.05.
5-(4-Chlorophenyl)-2-vinyl-2H-tetrazole (2e): Mobile phase: hexane/Et2O, 15:1.
Yield: 84%; mp 81–82 °C; 1H NMR (300 MHz, CDCl3) d: 8.13 (d, J = 8.7 Hz, 2H),
7.55 (dd, J = 15.6 and 8.8 Hz , 1H), 7.47 (d, J = 8.7 Hz, 2H), 6.27 (dd, J = 15.6 and
1.6 Hz, 1H), 5.41 (dd, J = 8.8 and 1.6 Hz, 1H) ppm; 13C NMR (75 MHz, CDCl3) d:
164.0, 136.7, 129.7, 129.2, 128.3, 125.4, 108.7 ppm; Anal. Calcd for C9H7ClN4: C,
52.31; H, 3.41; N, 27.11. Found: C, 52.29; H, 3.34; N, 27.2.
Acknowledgements
This work was supported by the Ministry of Education of the
Czech Republic (Project No. MSM0021620822) and by the Czech
Science Foundation (203/07/1302). We thank Professor Jirí Kuneš
ˇ
for obtaining NMR spectra.
Supplementary data
Supplementary data (general experimental details, copies of
NMR spectra, Table S1) associated with this article can be found,
N-[3-(2-Vinyl-2H-tetrazol-5-yl)phenyl]acetamide (2f): Mobile phase: Et2O/
hexane, 4:1. Yield: 77%; mp 153–154 °C; 1H NMR (300 MHz, CD3SOCD3) d:
10.18 (m, 1H), 8.41–8.45 (m, 1H), 7.89 (dd, J = 15.5 and 8.7 Hz, 1H), 7.70–7.80
(m, 2H), 7.45–7.52 (m, 1H), 6.18 (dd, J = 15.5 and 1.5 Hz, 1H), 5.56 (dd, J = 8.7
and 1.5 Hz, 1H), 2.07 (s, 3H) ppm; 13C NMR (75 MHz, CD3SOCD3) d: 168.8,
164.2, 140.3, 130.5, 130.0, 126.9, 121.3, 117.0, 109.7, 24.2 ppm; Anal. Calcd for
C11H11N5O: C, 57.63; H, 4.84; N, 30.55. Found: C, 57.49; H, 5.04; N, 30.47.
5-o-Tolyl-2-vinyl-2H-tetrazole (2g): Mobile phase: hexane/Et2O, 20:1. Yield:
78%; isolated as an oil; 1H NMR (300 MHz, CDCl3) d: 8.06–8.11 (m, 1H), 7.58
(dd, J = 15.6 and 8.8 Hz, 1H), 7.29–7.43 (m, 3H), 6.27 (dd, J = 15.6 and 1.5 Hz,
1H), 5.39 (dd, J = 8.8 and 1.5 Hz, 1H), 2.67 (s, 3H) ppm; 13C NMR (75 MHz,
CDCl3) d: 165.3, 137.7, 131.4, 130.2, 129.8, 129.6, 126.0, 125.9, 108.3,
21.7 ppm; HRMS (EI): m/z calcd for C10H10N4 [M]+: 186.0905; found: 186.0908.
5-(3,4-Dichlorophenyl)-2-vinyl-2H-tetrazole (2h): Mobile phase: hexane/Et2O,
References and notes
1. Herr, R. J. Bioorg. Med. Chem. 2002, 10, 3379.
2. Koldobskii, G. I.; Ostrovskii, V. A. Usp. Khim. 1994, 63, 847.
3. (a) Duncia, J. V.; Pierce, M. E.; Santella, J. B., III J. Org. Chem. 1991, 56, 2395; (b)
Amantini, D.; Beleggia, R.; Fringuelli, F.; Pizzo, F.; Vaccaro, L. J. Org. Chem. 2004,
69, 2896; (c) Aureggi, V.; Sedelmeier, G. Angew. Chem., Int. Ed. 2007, 46, 8440.
4. Demko, Z. P.; Sharpless, K. B. J. Org. Chem. 2001, 66, 7945.
5. Finnegan, W. G.; Henry, R. A.; Lofquist, R. J. Am. Chem. Soc. 1958, 80, 3908.